Back to Top

1:00–3:00 p.m.
Breakout Session A

A1.      Mini-Plenary—Developing a Trauma-Informed Treatment System
A2.      Mini-Plenary—Effective Engagement and Retention Strategies: Innovative Practices for Women in
           Substance Abuse Treatment
A3.      Community and Correctional Interventions for Women Offenders
A4.      Talking About Sex: A NIDA Clinical Trials Network Women’s HIV Prevention Trial
A5.      Treatment Issues and Strategies for Women With Methamphetamine Dependence and Their Children
A6.      Organizational Change for Smoking Cessation in Perinatal Drug Abuse Treatment

3:30–5:00 p.m.
Breakout Session B

B1.       Mini-Plenary—Dialectical Behavioral Therapy for Women
B2.       Mini-Plenary—Contingency Management With Women
            (Note: This session will repeat on Thursday.)
B3.       Fostering African-American Women’s Long-Term Recovery Through Religious Communities
B4.       Drinking Among College Women: Risk Factors, Consequences and Prevention Approaches
B5.       The Science of Relapse and Recovery Support
B6.       Cognitive-Behavioral Therapy With Women
            (Note: This session will repeat on Thursday.)

Back to Top

Advancing Women's Services: Partnering With the Field

H. Westley Clark, M.D., J.D., M.P.H.
Center for Substance Abuse Treatment

Dr. Clark, Director of the Center for Substance Abuse Treatment (CSAT), Substance Abuse and Mental Health Services Administration, leads the agency’s national effort to provide effective and accessible treatment to all Americans with addictive disorders. In his plenary presentation, Dr. Clark will draw from major national surveys and current research to highlight important findings regarding women with substance use disorders and their children and families. Key topic areas will include prevalence of substance use disorders, treatment need and receipt, treatment admission and services information, pregnant and parenting women, other special populations and gender-specific treatment outcomes. After discussing the research and its implications for treatment providers, Dr. Clark will provide an overview of CSAT grant programs that serve women, present a snapshot of current grantees and discuss CSAT’s future direction on women’s issues.

View Clark PowerPoint Presentation Video: Real | Windows

Substance Abuse: Does Gender Matter?

Cora Lee Wetherington, Ph.D.
Women and Gender Research Coordinator, National Institute on Drug Abuse

Over the past several years, the National Institute on Drug Abuse (NIDA) of the National Institutes of Health has been actively promoting a research agenda on gender differences in drug abuse. As recently as a decade ago, NIDA’s research efforts rarely focused on male–female differences. Today, however, NIDA supports gender-differences research in all of its major program areas. This research shows repeatedly that gender matters in the etiology, consequences, prevention and treatment of drug abuse. Dr. Wetherington will highlight some of the findings that have emerged in the past few years. Topics will include a new look at male–female differences in the epidemiology of drug abuse, gender differences in animal behavioral models, the role of the estrus/menstrual cycle and male–female differences in the pathways and progression to drug abuse, as well as in drug abuse treatment.

View Wetherington PowerPoint Presentation Video: Real | Windows

C1. Mini-Plenary—Cognitive-Behavioral Therapy With Women
Cognitive behavioral therapy (CBT) is a widely recognized empirically supported approach for a range of substance use and related disorders. After a review of the basics of CBT, Dr. Carroll will discuss recent evidence on the durability of cognitive behavioral approaches and explore the specific treatment components that may foster CBT’s durability. She will present evidence from a number of recent clinical trials involving diverse populations with substance use disorders on the extent to which women differ from men in terms of response to CBT. Throughout the workshop, the clinical aspects of implementing CBT will be highlighted.

Presenter:
Kathleen M. Carroll, Ph.D.
Yale University School of Medicine
New Haven, CT

View Carroll PowerPoint Presentation Video: Real | Windows

 

C2. Mini-Plenary—Contingency Management With Women
Contingency management is one of the most powerful interventions to initiate and sustain abstinence from substance use. This mini-plenary will address what is known about existing gender differences in outcomes between men and women treated with contingency management and how contingency management can be tailored to effectively improve drug treatment outcomes in both genders. A novel therapy, Reinforcement Behavioral Therapy (RBT), that incorporates contingency management as part of the treatment package will be presented. The basic premise of this therapy is to reward positive behavior and empower women to make changes in behavior that improve their lives. Presenters will explain the orientation, development and research outcomes and tools of this therapy to enable clinicians to put contingency management research into practice. The specific tailoring of this therapy to pregnant and postpartum women with substance use disorders will be described. Specific tools of RBT and contingency management to help women maintain drug abstinence and make life improvements will be offered in a manner that will allow clinicians to directly apply these tools in a variety of clinical settings.

Presenters:
Hendrée E. Jones, Ph.D.
Johns Hopkins University
Baltimore, MD

Michelle Tuten, LCSW
Johns Hopkins University
Baltimore, MD

View Session C2 PowerPoint Presentation

 

C3. Treatment of Women in Culturally Diverse Populations, Part 1
This session will provide an overview of issues that may influence the treatment and recovery of women of color who are drug addicted and/or may be at risk for drug use and/or addiction. A framework for understanding and appreciating cultural factors and experiences that may influence treatment and recovery in women of color will be presented. Issues of race/ethnicity and gender will be discussed as important forces that may affect the lives of women of color both positively, through cultural traditions and supports, and negatively, through social forces of racism and sexism at the individual and institutional levels. In particular, the impact of systems of racism and sexism, and the resulting creation of dominant and subordinate social groups, on risk of drug use in women of color will be discussed. Gender inequalities, which may include experiences based on poverty, childhood physical and sexual abuse, domestic violence, rape and sexual harassment and their influence on risk and patterns of drug use for women of color will also be addressed. Finally, the impact of historical trauma on women’s drug use in comunities of color and implications for treatment will be discussed. This workshop complements the later roundtable session, D.4. Treatment of Women in Culturally Diverse Populations, Part 2, which will address specific clinical practice and
treatment issues in more depth.

Presenter:
Kathy Sanders-Phillips, Ph.D.
Center for Drug Abuse Research, Howard University
Washington, DC

View Sanders-Phillips PowerPoint Presentation

 

C4. Psychological Well-Being and Risk Reduction in HIV-Positive Women With Histories of Trauma
When providing HIV prevention and treatment services, providers too often neglect to address a woman’s mental health needs and how being HIV positive can affect a woman’s overall well-being. This presentation will highlight findings from more than a decade of research, conducted by the UCLA Sexual Health Program, with HIV-positive women from various multiethnic groups. Findings that capture the cycle of psychological distress and sexual- and drug-related risk taking will highlight the importance of assessing and treating both women’s mental and physical health in women-centered healthcare programs. The speaker will discuss challenges and strategies for meeting the health and mental health treatment and service needs of HIV-positive women.

Presenter:
Gail E. Wyatt, Ph.D.
UCLA Semel Institute for Neuroscience and Human Behavior
UCLA Sexual Health Program
Center for Trauma and Mental Health Disparities
UCLA AIDS Institute
Los Angeles, CA

View Wyatt PowerPoint Presentation

 

C5. Engaging Moms Dependency Drug Court: Programmatic Innovation and Research Results
An estimated 3 million children are abused and neglected each year, 50 to 70 percent of whom have mothers with substance use disorders. Judicial and child welfare systems throughout the Nation have turned to family drug courts as a possible solution to this problem. The Miami Engaging Moms Drug Court Model, based on an evidence-based intervention called the Engaging Moms Program (EMP), is a family-oriented intervention that has proven effective in facilitating the entry of mothers with substance use problems into treatment. This multidisciplinary panel will provide an overview of the Miami Engaging Moms Drug Court, from both judicial and clinical perspectives. Presenters will review the court’s structure and procedures, outline the role of the judge and discuss the therapeutic processes of court hearings. The panel will also describe in detail the implementation of the program and its clinical interventions, including culture- and gender-specific components. Case presentations will be provided, and both parent and child outcomes of a National Institute on Drug Abuse-funded randomized clinical trial will be presented.

Presenters:
Gayle Dakof, Ph.D.
University of Miami School of Medicine
Miami, FL

Jeri B. Cohen, J.D.
11th Judicial Circuit Court, State of Florida
Miami, FL

Eliette Duarte, LMHC
University of Miami School of Medicine
Miami, FL

View Session C5 PowerPoint Presentation

 

C6. Impact of Prenatal Methamphetamine Exposure on Child Development
This workshop will review current knowledge about the effect of methamphetamine exposure on infants and children. Dr. Shah will present and discuss outcomes data from a 5-year follow-up of children prenatally exposed to methamphetamine, cocaine and cocaine/methamphetamine who have received services from the CAIRE (Child and Infant Recovery Effort) program at Blank Children’s Hospital in Des Moines, Iowa. The CAIRE program provides early identification, comprehensive assessment and intervention services to drug-exposed infants and children. Dr. Shah will discuss multidisciplinary, collaborative interventions for special needs such as occupational and physical therapy, speech therapy or psychological evaluations and family-centered coordination of in-home services for drug-exposed infants and children. Dr. LaGasse will discuss preliminary results from the National Institute on Drug Abuse-funded Infant Development, Environment and Lifestyle (IDEAL) study, a multicenter, longitudinal investigation of the effects of prenatal methamphetamine exposure.

Presenters:
Rizwan Shah, M.D.
Regional Child Protection Center, Blank Children’s Hospital
Des Moines, IA

View Shah PowerPoint Presentation

Linda L. LaGasse, Ph.D.
Brown Center for the Study of Children at Risk
Women and Infants Hospital
Providence, RI

View LaGasse PowerPoint Presentation

 

D1. Mini-Plenary—Juvenile Justice Girls: Profiles and Implementation of Gender-Responsive Treatment
Females are the fastest growing segment of the juvenile justice population. The multidimensional nature of girls’ problems (e.g., histories of victimization, unstable family lives, school failure, repeated status offenses and mental and substance use disorders) highlights the complexity of providing appropriate services to meet their needs. This mini-plenary will present recent findings on girls in correctional facilities from the National Institute on Drug Abuse-funded Criminal Justice Drug Abuse Treatment Studies (CJ-DATS). Presenters will highlight information on juvenile justice girls’ sociodemographics, drug use, delinquency and crime and emotional/psychiatric status and discuss how these factors relate to their unique treatment needs. The multidisciplinary panel will then discuss VOICES: A Program of Self-Discovery and Empowerment for Girls, a gender-responsive, trauma-informed intervention that is grounded in theories of psychological development, attachment, resilience, addiction and trauma. Its therapeutic approach is group-based and includes psychoeducational, cognitive behavioral, expressive arts and relational therapy strategies. Presenters will address the program’s implementation in juvenile justice settings, focusing on key implementation issues such as recruitment, oversight and supervision.

Presenters:
Stephanie S. Covington, Ph.D., LCSW
Center for Gender and Justice and Institute for Relational Development
La Jolla, CA

View Covington PowerPoint Presentation

Nancy Jainchill, Ph.D.
Center for Therapeutic Community Research
National Development & Research Institutes
New York, NY

View Jainchill PowerPoint Presentation

Pamela S. Hardy
New York City Department of Probation
New York, NY

Audrey Wilson
New York City Department of Probation
New York, NY

View Hardy and Wilson PowerPoint Presentation

View Session D1 presentation video: Real | Windows

 

D2. Mini-Plenary—Implementing an Integrated Treatment Continuum of Women-Sensitive Services
This mini-plenary session will describe a treatment continuum designed to provide the most effective treatments for women with substance abuse issues and their children. Presenters will discuss research findings from four different studies that illustrate an integrated continuum of services for women and demonstrate community-level implementation of a number of evidence-based practices. The panel will discuss the development and implementation of the following components of this integrated treatment continuum of women-sensitive services: an innovative community-based assessment center, an evidence-based intervention for trauma-informed and trauma-specific substance abuse treatment for women, an evidence-based brief substance abuse treatment intervention for adolescent females (the motivational enhancement therapy [MET]/cognitive-behavioral therapy [CBT]5) and integrated substance abuse and mental health services for women living with HIV/AIDS and their families. The presenters will highlight data available from the application of these various evidence-based practices in community settings with a diverse population of women. For each study, issues of cultural competence and specifically woman-centered treatment approaches will be discussed.

Presenters:
Vivian B. Brown, Ph.D.
PROTOTYPES, Centers for Innovation in Health, Mental Health and Social Services
Culver City, CA

View Brown PowerPoint Presentation

Lisa A. Melchior, Ph.D.
The Measurement Group LLC
Culver City, CA

View Melchior PowerPoint Presentation

Olga Tuller, Ph.D.
PROTOTYPES, Outpatient and Day Treatment Center
Pomona, CA

View Tuller PowerPoint Presentation

Ruth Slaughter
PROTOTYPES, Community Outreach, Prevention and Education Programs
Culver City, CA

View Slaughter Presentation

 

D3. Improving Treatment Utilization and Outcome in Pregnant Women With Substance Use Disorders
An estimated 5 percent of women use illicit substances during pregnancy, with approximately 22 percent of those who use illicit substances also reporting the use of tobacco or alcohol. Although treatment programs specifically designed for pregnant women who abuse substances generally have greater success rates compared with programs that do not make provisions for the needs of pregnant women, treatment retention continues to be a problem. Evidence suggests that longer treatment retention of pregnant women who use substances is associated with decreased substance use and better birth outcomes. Increasing treatment utilization has thus been identified as an important goal for programs treating pregnant women who use substances. Brief motivational techniques, such as motivational interviewing and motivational enhancement therapy, have recently been explored as methods for improving treatment outcomes with pregnant women who use substances. This workshop will introduce the use of such techniques and discuss key implementation issues. Presenters will provide a brief overview of the challenges faced in retaining pregnant women who use substances in treatment, review the evidence-based literature regarding brief motivational interventions in pregnant women who use substances, identify the conceptual basis and elements of successful brief motivational interventions and discuss the implementation of a three-session motivational intervention used in a recent NIDA Clinical Trials Network study, “Motivational Enhancement Therapy to Improve Treatment Utilization and Outcome in Pregnant Substance Users.”

Presenters:
Theresa Winhusen, Ph.D.
University of Cincinnati College of Medicine
Cincinnati, OH

Frankie Kropp, M.S.
Cincinnati Addiction Research Center
Cincinnati, OH

View Session D3 PowerPoint Presentation

View Session D3 Handout

 

D4. Treatment of Women in Culturally Diverse Populations, Part 2
This roundtable discussion will focus on identifying and fostering effective and culturally appropriate substance abuse treatment programs and systems of care that adequately support the unique and diverse needs of four racial and ethnic groups: African American, Asian, Hispanic and Native American. After a brief introduction and overview of the prominent issues and challenges that both cut across and are unique to the groups, the four panelists will engage in a spirited discussion about effective approaches they use and are advocating for to provide services to diverse and unique populations. They will also answer participants’ questions about best practices and how to implement culturally competent models in participants’ treatment settings. This roundtable, in addressing more specific clinical practice and treatment issues, will complement the breakout session C3. Treatment of Women in Culturally Diverse Populations, Part I, which will outline the latest research advances in this area.

Presenters:
Karen Allen, Ph.D., RN
Andrews University
Berrien Springs, MI

Constance Falleaf
White Bison
Norman, OK

View Falleaf PowerPoint Presentation

Juana Mora, Ph.D.
California State University Northridge
Northridge, CA

View Mora PowerPoint Presentation

Ann S. Yabusaki, Ph.D.
Coalition for a Drug-Free Hawaii
Kaneohe, HI

View Yabusaki PowerPoint Presentation

 

D5. Can You Hear Me Now? An Innovative Approach to Promoting Continued Treatment
Keeping women in treatment across levels of care is a challenge for treatment providers. To respond to this challenge, the Betty Ford Center (BFC) developed a telephone intervention to encourage continuing care and recovery activities. Following BFC basic guidelines, the NIDA Clinical Trials Network tested the effectiveness of supportive telephone calls to increase attendance at continuing care appointments. The results suggest that the intervention was effective in increasing aftercare attendance and that female gender was a predictor of a positive outcome. This workshop will present background information and outcomes of the research, discuss the implementation of research in a community treatment program and encourage workshop participants to consider the pros and cons of adopting this innovative practice, particularly for women in treatment. In addition, participants will have an opportunity to see a role play demonstration of the telephone counseling format and practice using the intervention.

Presenters:
Louise Haynes, M.S.W.
Lexington Richland Alcohol and Drug Abuse Council
Columbia, SC

Nancy Waite-O’Brien, Ph.D.
Betty Ford Center
Rancho Mirage, CA

View Haynes & Waite-O'Brien PowerPoint Presentation

 

D6. Smoking Cessation for Women and Pregnant Women
In 2004, an estimated 23 percent of American women smoked, including 18 percent of pregnant women. Although historically smoking was more common among men, the gap in prevalence rates for men and women has narrowed. Women who smoke—and pregnant women and their babies, in particular—face special health risks. The history of smoking in women differs significantly from that of men; women more often report that they smoke to deal with stress and emotion. Effective treatments for smoking cessation exist. Providers need to be aware that women who smoke may benefit from treatments that address gender differences in smoking behaviors. In this workshop, the presenters will review evidence-based treatments for women who smoke, with an emphasis on gender differences in response to pharmacologic and psychological treatments and issues related to mood and weight concerns. The presenters will review and describe specialized treatments for pregnant and postpartum women and provide information on how to implement these approaches.

Presenters:
Michele Levine, Ph.D.
Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center
Pittsburgh, PA

View Levine PowerPoint Presentation

Sarah H. Heil, Ph.D.
Department of Psychology, University of Vermont College of Medicine
Burlington, VT

View Heil PowerPoint Presentation

View Document